سعر تيماسبان Timaspan 1000مجم 10 اقراص 2026
Timaspan 1000 mg 10 ext. rel. f.c. tabsدواعي استعمال تيماسبان 1000
- Adjunct to diet to reduce elevated TC, LDL-C, Apo B and TG and to increase HDL-C in primary hyperlipidemia and mixed dyslipidemiaالفئة: AdultsDailyMed (U.S. National Library of Medicine)
- Adjunctive therapy in adults with severe hypertriglyceridemia at risk of pancreatitisالفئة: AdultsDailyMed (U.S. National Library of Medicine)
- Adjunct to diet to reduce elevated TC, LDL-C, Apo B and TG and to increase HDL-C in primary hyperlipidemia and mixed dyslipidemiaPopulation: AdultsDailyMed (U.S. National Library of Medicine)
- Adjunctive therapy in adults with severe hypertriglyceridemia at risk of pancreatitisPopulation: AdultsDailyMed (U.S. National Library of Medicine)
معلومات الدواء
التفاصيل الكاملةالآثار الجانبيةSide effects
- Most common (>5% and greater than placebo): flushing, diarrhea, nausea, vomiting, increased cough and pruritus.نشرة دولية لنفس التركيبة · DailyMed (U.S. National Library of Medicine)
- Most common (>5% and greater than placebo): flushing, diarrhea, nausea, vomiting, increased cough and pruritus.International label, same formulation · DailyMed (U.S. National Library of Medicine)
موانع الاستعمالContraindications
- Active liver disease or unexplained persistent elevations in hepatic transaminases; active peptic ulcer disease; arterial bleeding; hypersensitivity to niacin or any component.نشرة دولية لنفس التركيبة · DailyMed (U.S. National Library of Medicine)
- Active liver disease or unexplained persistent elevations in hepatic transaminases; active peptic ulcer disease; arterial bleeding; hypersensitivity to niacin or any component.International label, same formulation · DailyMed (U.S. National Library of Medicine)
تحذيرات واحتياطاتWarnings & precautions
- Extended-release niacin must not be substituted for equivalent doses of immediate-release niacin; severe hepatic toxicity has occurred with such substitution. Risk of myopathy/rhabdomyolysis, especially with statins.نشرة دولية لنفس التركيبة · DailyMed (U.S. National Library of Medicine)
- Extended-release niacin must not be substituted for equivalent doses of immediate-release niacin; severe hepatic toxicity has occurred with such substitution. Risk of myopathy/rhabdomyolysis, especially with statins.International label, same formulation · DailyMed (U.S. National Library of Medicine)
التداخلات الدوائيةDrug interactions
- StatinsCaution: increased risk of myopathy/rhabdomyolysis with niacin (>=1 g/day).DailyMed (U.S. National Library of Medicine)
- Bile acid sequestrantsSeparate by 4-6 hours (sequestrant taken before niacin) because of high niacin-binding capacity.DailyMed (U.S. National Library of Medicine)
- Antihypertensives / vasoactive drugsNiacin may potentiate ganglionic blockers and vasoactive drugs, causing postural hypotension.DailyMed (U.S. National Library of Medicine)
- StatinsCaution: increased risk of myopathy/rhabdomyolysis with niacin (>=1 g/day).DailyMed (U.S. National Library of Medicine)
- Bile acid sequestrantsSeparate by 4-6 hours (sequestrant taken before niacin) because of high niacin-binding capacity.DailyMed (U.S. National Library of Medicine)
- Antihypertensives / vasoactive drugsNiacin may potentiate ganglionic blockers and vasoactive drugs, causing postural hypotension.DailyMed (U.S. National Library of Medicine)
تابع أسعار الأدوية أول بأول
بننشر كل يوم أسعار أدوية اتغيرت والبدائل الأرخص
المعرّفات
- تصنيف ATC
- مراجع علمية للمادة الفعالة
- Niacin (nicotinic acid)PubChem (يفتح في نافذة جديدة)
أدوية ذات صلة
نفس المادة الفعالة بتركيز آخر
منتجات أخرى من Al Esraa Pharmaceutical Optima
المصادر
- السعر: قوائم أسعار الأدوية المنشورة في مصر.
- DailyMed (U.S. National Library of Medicine)
- PubChem (NCBI)
- WHO Collaborating Centre for Drug Statistics Methodology (ATC/DDD Index)
تعليقات
لا توجد تعليقات بعد. كن أول من يشارك تجربته مع هذا الدواء.
أضف تعليقًا